Does the Age-Related Eye Disease Study 2 (AREDS2) supplement increase bleeding risk?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Does AREDS2 Cause Bleeding?

No, AREDS2 supplements do not cause bleeding or increase bleeding risk. There is no documented association between AREDS2 formulation components and bleeding complications in the clinical trials or guidelines.

Evidence from Clinical Trials

The AREDS2 study, which enrolled 4,203 participants and followed them for a median of 5 years, did not identify bleeding as an adverse effect of the supplement formulation 1. The study specifically evaluated:

  • Lutein/zeaxanthin (10 mg/2 mg)
  • Omega-3 fatty acids (DHA 350 mg + EPA 650 mg)
  • Background AREDS vitamins and minerals (vitamins C, E, zinc, copper)

Documented Adverse Effects (Not Including Bleeding)

The actual adverse effects documented in guidelines and trials include 2:

Beta-Carotene Related:

  • Increased lung cancer risk in current and former smokers (18% excess cumulative incidence; relative risk 1.28,95% CI 1.04-1.57)
  • Self-reported skin yellowing (8.3% vs 6.0% in controls)

Zinc Related:

  • Genitourinary complications requiring hospitalization (7.5% with 80 mg zinc vs 4.9% without; P=0.001)
  • Includes urinary tract infections, prostatic hyperplasia in men, and stress incontinence in women
  • Risk of copper-deficiency anemia if copper not co-administered

Gastrointestinal:

  • Gastrointestinal symptoms were the main reported adverse effect across supplement groups 3

Cardiovascular Safety Data

A dedicated cardiovascular outcomes ancillary study (AREDS2-COS) specifically evaluated 602 cardiovascular events over 4.8 years and found no increased risk of myocardial infarction, stroke, or cardiovascular death with either omega-3 fatty acids or lutein/zeaxanthin supplementation 4. This comprehensive cardiovascular assessment would have captured any bleeding-related complications, and none were reported.

Clinical Implications

Bleeding is not a concern with AREDS2 supplementation. The primary safety considerations you should discuss with patients are:

  • Avoid beta-carotene in current or former smokers due to lung cancer risk
  • Monitor for genitourinary symptoms, particularly in men taking high-dose zinc
  • Ensure copper supplementation is included with zinc to prevent anemia
  • Coordinate with primary care physicians for overall supplement review 2

The omega-3 fatty acids in AREDS2 (1 gram total daily) are at doses that have not demonstrated bleeding risk in this elderly population, even in those with existing cardiovascular disease.

budget:budget_used 7832 6950 882 0.052

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.